Literature DB >> 23851558

Statin-induced diabetes: too sweet a deal?

Ricky Turgeon1, G Michael Allan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23851558      PMCID： PMC3710061     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  13 in total

1.  Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials.

Authors:  David D Waters; Jennifer E Ho; David A DeMicco; Andrei Breazna; Benoit J Arsenault; Chuan-Chuan Wun; John J Kastelein; Helen Colhoun; Philip Barter
Journal:  J Am Coll Cardiol       Date:  2011-04-05       Impact factor: 24.094

2.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

3.  Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis.

Authors:  William J Elliott; Peter M Meyer
Journal:  Lancet       Date:  2007-01-20       Impact factor: 79.321

4.  The diabetes risk score: a practical tool to predict type 2 diabetes risk.

Authors:  Jaana Lindström; Jaakko Tuomilehto
Journal:  Diabetes Care       Date:  2003-03       Impact factor: 19.112

5.  Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.

Authors:  Naveed Sattar; David Preiss; Heather M Murray; Paul Welsh; Brendan M Buckley; Anton J M de Craen; Sreenivasa Rao Kondapally Seshasai; John J McMurray; Dilys J Freeman; J Wouter Jukema; Peter W Macfarlane; Chris J Packard; David J Stott; Rudi G Westendorp; James Shepherd; Barry R Davis; Sara L Pressel; Roberto Marchioli; Rosa Maria Marfisi; Aldo P Maggioni; Luigi Tavazzi; Gianni Tognoni; John Kjekshus; Terje R Pedersen; Thomas J Cook; Antonio M Gotto; Michael B Clearfield; John R Downs; Haruo Nakamura; Yasuo Ohashi; Kyoichi Mizuno; Kausik K Ray; Ian Ford
Journal:  Lancet       Date:  2010-02-16       Impact factor: 79.321

6.  Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials.

Authors:  Dennis T Ko; Patricia R Hebert; Christopher S Coffey; Jeptha P Curtis; JoAnne M Foody; Artyom Sedrakyan; Harlan M Krumholz
Journal:  Arch Intern Med       Date:  2004-07-12

Review 7.  Effectiveness of statin therapy in adults with coronary heart disease.

Authors:  Timothy J Wilt; Hanna E Bloomfield; Roderick MacDonald; David Nelson; Indulis Rutks; Michael Ho; Gregory Larsen; Anthony McCall; Sandra Pineros; Anne Sales
Journal:  Arch Intern Med       Date:  2004-07-12

8.  Effect of statins on fasting plasma glucose in diabetic and nondiabetic patients.

Authors:  Rishi Sukhija; Sastry Prayaga; Mohammad Marashdeh; Zoran Bursac; Priyanka Kakar; Darpan Bansal; Rajesh Sachdeva; Sree Hari Kesan; Jawahar L Mehta
Journal:  J Investig Med       Date:  2009-03       Impact factor: 2.895

9.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321

10.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112
View more
  2 in total

1.  Does ezetimibe modify clinical outcomes?

Authors:  Ricky D Turgeon; Kelly B Zarnke; G Michael Allan
Journal:  Can Fam Physician       Date:  2015-03       Impact factor: 3.275

2.  Simplified lipid guidelines: Prevention and management of cardiovascular disease in primary care.

Authors:  G Michael Allan; Adrienne J Lindblad; Ann Comeau; John Coppola; Brianne Hudson; Marco Mannarino; Cindy McMinis; Raj Padwal; Christine Schelstraete; Kelly Zarnke; Scott Garrison; Candra Cotton; Christina Korownyk; James McCormack; Sharon Nickel; Michael R Kolber
Journal:  Can Fam Physician       Date:  2015-10       Impact factor: 3.275
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.